Journal of the American Chemical Society
ARTICLE
7.11 (t, 2H, J = 7.32 Hz), 7.28-7.33 (m, 4H), 7.65 (d, 2H, J = 13.20 Hz).
13C NMR (75 MHz, CDCL3): δ 21.6, 25.3, 28.8, 31.0, 47.0, 48.0, 55.1,
95.8, 109.1, 122.0, 123.4, 123.8, 128.3, 140.0, 140.9, 143.2, 158.0, 169.7.
HRMS (ESIþ) Calcd for [M - ClO4-]: 533.3644, found: 533.3680.
Synthesis of IR786-N-Benzylpiperazine (6). IR-786 perchlo-
rate (60 mg, 0.1 mmol) was dissolved in anhydrous DMF (5 mL), and
1-benzylpiperazine (70 mg, 0.4 mmol) was added. The mixture was
stirred at room temperature for 3 h under an argon atmosphere. The
solvent was removed under reduced pressure, then the crude product
was purified by silica gel chromatography with dichloromethane and
methanol, and washed with n-hexane to afford a glossy blue solid (62 mg,
86%). 1H NMR (300 MHz, CDCl3): δ 1.62 (s, 12H), 1.78-1.87 (m,
2H), 2.42 (br, 4H), 2.48 (t, 4H, J = 6.4 Hz, f), 3.49 (s, 6H), 3.74 (s, 2H),
3.78 (br, 4H), 5.76 (d, 2H, J = 13.4 Hz), 7.00 (d, 2H, J = 7.8 Hz), 7.12 (t,
2H, J = 7.5 Hz), 7.28-7.40 (m, 7H), 7.59 (d, 2H, J = 13.4 Hz). 13C NMR
(75 MHz, CDCl3): δ 21.6, 24.9, 28.8, 30.8, 47.8, 54.1, 55.0, 62.9, 96.0,
109.1, 121.8, 123.4, 124.4, 127.5, 128.4, 128.5, 129.4, 136.6, 139.9, 141.1,
143.2, 169.1, 173.7. HRMS (ESIþ): Calcd for [M - ClO4-]: 623.4139,
found: 623.4113.
Synthesis of pH Probe 7. IR-783 perchlorate (80 mg, 0.1 mmol)
was dissolved in anhydrous DMF (5 mL), and piperazine (43 mg, 0.4
mmol) was added. The mixture was stirred at 80 °C for 1.5 h under an
argon atmosphere. 4-Bromophenylacetic acid (275 mg, 1.2 mmol) was
added, and stirred at 60 °C under an argon atmosphere overnight. The
reaction mixture was poured into 200 mL of diethylether. The precipitate
was collected by filtration, and purified by HPLC to afford a blue solid
(13 mg, 14%). 1H NMR (400 MHz, CD3OD): δ 1.53 (s, 12H), 1.70-1.83
(m, 10H), 2.42 (t, 4H, J = 6.40 Hz), 2.72-2.78 (m, 8H), 3.52 (s, 2H),
3.67 (br, 4H), 3.71 (s, 2H), 3.94 (br, 4H), 5.89 (d, 2H, J = 13.20 Hz),
6.79-6.93 (m, 2H), 7.03-7.34 (m, 12H), 7.63 (d, 2H, J = 13.20 Hz).
13C NMR (100 MHz, CD3OD): δ 23.0, 23.6, 25.8, 26.9, 29.2, 43.0, 44.1,
44.8, 52.0, 55.2, 55.8, 63.4, 97.5, 110.9, 123.2, 124.7, 125.8, 129.6, 130.5,
131.0, 131.1, 135.6, 141.8, 143.0, 144.1, 170.7, 174.6. HRMS (ESIþ)
Calcd for [M þ Hþ]: 925.4243, found: 925.4195.
Technology Development Organization (NEDO) of Japan (to
T.T.). K.H. was also supported by Sankyo Foundation of Life
Science.
’ REFERENCES
(1) Montcourrier, P.; Mangeat, P. H.; Valembois, C.; Salazar, G.;
Sahuquet, A.; Duperray, C.; Rochefort, H. J. Cell Sci. 1994, 107, 2381–
2391.
(2) Cousin, M. A.; Nicholls, D. G. J. Neurochem. 1997, 69, 1927–
1935.
(3) Sun, W. C.; Gee, K. R.; Klaubert, D. H.; Haugland, R. P. J. Org.
Chem. 1997, 62, 6469–6475.
(4) Overly, C. C.; Lee, K. D.; Berthiaume, E.; Hollenbeck, P. J. Proc.
Natl. Acad. Sci. U. S. A. 1995, 92, 3156–3160.
(5) Rurack, K.; Kollmannsberger, M.; Daub, J. New J. Chem. 2001,
25, 289–292.
(6) Weissleder, R. Nat. Biotechnol. 2001, 19, 316–317.
(7) Frangioni, J. V. Curr. Opin. Chem. Biol. 2003, 7, 626–634.
(8) Weissleder, R.; Pittet, M. J. Nature 2008, 452, 580–589.
(9) Szacilowski, K.; Macyk, W.; Drzewiecka-Matuszek, A.; Brindell,
M.; Stochel, G. Chem. Rev. 2005, 105, 2647–2694.
(10) Encinas, C.; Miltsov, S.; Otazo, E.; Rivera, L.; Puyol, M.;
Alonso, J. Dyes Pigm. 2006, 71, 28–36.
(11) Zhang, Z. R.; Achilefu, S. Chem. Commun. 2005, 5887–5889.
(12) Cooper, M. E.; Gregory, S.; Adie, E.; Kalinka, S. J. Fluores. 2002,
12, 425–429.
(13) Hilderbrand, S. A.; Weissleder, R. Chem. Commun. 2007, 2747–
2749.
(14) Kiyose, K.; Kojima, H.; Urano, Y.; Nagano, T. J. Am. Chem. Soc.
2006, 128, 6548–6549.
(15) Kiyose, K.; Aizawa, S.; Sasaki, E.; Kojima, H.; Hanaoka, K.;
Terai, T.; Urano, Y.; Nagano, T. Chem.—Eur. J. 2009, 15, 9191–9200.
(16) Yu, Y. H.; Descalzo, A. B.; Shen, Z.; Rohr, H.; Liu, Q.; Wang,
Y. W.; Spieles, M.; Li, Y. Z.; Rurack, K.; You, X. Z. Chem. Asian J. 2006,
1, 176–187.
(17) Ziessel, R.; Ulrich, G.; Harriman, A.; Alamiry, M. A. H.; Stewart,
B.; Retailleau, P. Chem.—Eur. J. 2009, 15, 1359–1369.
(18) Urano, Y.; Asanuma, D.; Hama, Y.; Koyama, Y.; Barrett, T.;
Kamiya, M.; Nagano, T.; Watanabe, T.; Hasegawa, A.; Choyke, P. L.;
Kobayashi, H. Nat. Med. 2009, 15, 104–109.
(19) Han, J.; Burgess, K. Chem. Rev. 2010, 110, 2709–2728.
(20) Ohkuma, S.; Poole, B. Proc. Natl. Acad. Sci.U. S. A. 1978,
75, 3327–3331.
’ ASSOCIATED CONTENT
S
Supporting Information. Detailed descriptions of syn-
b
thetic procedure for 8; data on the measurements of absorption
spectra of 8 with 0.1% or 10% DMSO as a cosolvent, and on the
measurements of absorption spectra of 8 in the presence of 500
mM NaCl; plot of the changes of absorbance intensities of 8;
relative fluorescence ratios of 8 at various temperatures; fluores-
cence intensities of nano beads-probe 7 conjugate after a day;
time-dependent changes of absorption spectra of 7; confocal
fluorescence images of live cells. This material is available free of
(21) Whitaker, J. E.; Haugland, R. P.; Prendergast, F. G. Anal.
Biochem. 1991, 194, 330–344.
’ AUTHOR INFORMATION
Corresponding Author
Author Contributions
These authors contributed equally.
’ ACKNOWLEDGMENT
This work was supported in part by a Grant-in-Aid for JSPS
Fellows, by grants from the Ministry of Education, Culture,
Sports, Science and Technology of Japan [Grant Nos. 22000006
(Specially Promoted Research) to T.N., 20689001 and
21659204 to K.H.), and by the Industrial Technology Research
Grant Program in 2009 from the New Energy and Industrial
3409
dx.doi.org/10.1021/ja1063058 |J. Am. Chem. Soc. 2011, 133, 3401–3409